AnalystsLuca IssiLuca Issi's Stock Forecasts
AnalystsLuca Issi
Sectors:
Industries:
Analyst Ranking
Top 7%
#326 out of 5075 analysts
Average Return
+17.34%
Win Rate
51%69 out of 134
Risk vs Reward
Poor
Good
Luca Issi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Uniqure NvQURE | +728.63% | $7.16 | $59.33 | 2024-11-06 - 2025-10-23 | Buy |
Uniqure NvQURE | +297.92% | $14.91 | $59.33 | 2025-01-21 - 2025-10-23 | Buy |
Uniqure NvQURE | +279.11% | $15.65 | $59.33 | 2024-12-11 - 2025-10-23 | Buy |
4d Molecular Therapeutics IncFDMT | +141.55% | $4.14 | $10.00 | 2025-03-03 - 2025-10-23 | Buy |
Intellia Therapeutics IncNTLA | +139.94% | $10.79 | $25.89 | 2025-08-08 - 2025-10-23 | Buy |
Luca Issi Analyst Color
Get additional color on Luca Issi's coverage of popular stocks
Luca Issi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals IncALNY | 27 | Buy | $500.00 | +7.76% | Maintains | a month ago |
Ionis Pharmaceuticals IncIONS | 9 | Buy | $80.00 | +11.89% | Maintains | 2 months ago |
Argenx SeARGX | 1 | Buy | $850.00 | +4.66% | Initiates Coverage On | 2 months ago |
Regenxbio IncRGNX | 9 | Buy | $17.00 | +35.14% | Maintains | 3 months ago |
Intellia Therapeutics IncNTLA | 5 | Buy | $21.00 | -18.89% | Maintains | 3 months ago |
Ascendis Pharma AASND | 3 | Buy | $230.00 | +14.42% | Maintains | 3 months ago |
Arrowhead Pharmaceuticals IncARWR | 9 | Buy | $38.00 | +1.74% | Maintains | 3 months ago |
Crispr Therapeutics AgCRSP | 13 | Hold | $42.00 | -37.51% | Maintains | 3 months ago |
Fulcrum Therapeutics IncFULC | 1 | Hold | $5.00 | -44.13% | Maintains | 3 months ago |
Dyne Therapeutics IncDYN | 3 | Buy | $23.00 | +39.48% | Maintains | 3 months ago |
Adverum Biotechnologies IncADVM | 8 | Hold | $4.00 | -4.31% | Maintains | 5 months ago |
Allogene Therapeutics IncALLO | 8 | Buy | $10.00 | +726.45% | Reiterates | 5 months ago |
Apellis Pharmaceuticals IncAPLS | 7 | Hold | $18.00 | -37.08% | Maintains | 6 months ago |
Moderna IncMRNA | 17 | Hold | $28.00 | +6.67% | Maintains | 6 months ago |
Lexeo Therapeutics IncLXEO | 5 | Buy | $20.00 | +122.22% | Maintains | 7 months ago |
Korro Bio IncKRRO | 7 | Buy | $95.00 | +153.33% | Maintains | 7 months ago |
Sangamo Therapeutics IncSGMO | 6 | Hold | $2.00 | +204.41% | Reiterates | 7 months ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $17.00 | +48.60% | Initiates Coverage On | 7 months ago |
Meiragtx Holdings PLCMGTX | 6 | Buy | $13.00 | +48.57% | Maintains | 7 months ago |
Verve Therapeutics IncVERV | 7 | Buy | $15.00 | +34.77% | Maintains | 8 months ago |
4d Molecular Therapeutics IncFDMT | 7 | Buy | $35.00 | +250.00% | Maintains | 8 months ago |
Beam Therapeutics IncBEAM | 7 | Hold | $26.00 | -7.80% | Maintains | 8 months ago |
Biomarin Pharmaceutical IncBMRN | 12 | Hold | $70.00 | +28.32% | Reiterates | 8 months ago |
Uniqure NvQURE | 6 | Buy | $24.00 | -59.55% | Reiterates | 9 months ago |
Schlumberger LimitedSLB | 1 | Buy | $57.00 | +58.29% | Reiterates | 9 months ago |
Avidity Biosciences IncRNA | 2 | Buy | $67.00 | +38.00% | Reiterates | 9 months ago |
Editas Medicine IncEDIT | 8 | Hold | $4.00 | +9.59% | Maintains | 10 months ago |
Bluebird Bio IncBLUE | 4 | Hold | $80.00 | +1,509.66% | Reiterates | a year ago |
Ultragenyx Pharmaceutical IncRARE | 3 | Buy | $77.00 | +128.96% | Reiterates | a year ago |
Wave Life Sciences LtdWVE | 5 | Hold | $15.00 | N/A | Maintains | a year ago |
Caribou Biosciences IncCRBU | 5 | Buy | $14.00 | N/A | Reiterates | a year ago |
Lenz Therapeutics IncLENZ | 3 | Hold | $3.00 | N/A | Maintains | 3 years ago |
Q32 Bio IncQTTB | 3 | Hold | $54.00 | N/A | Maintains | 3 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $38.25 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.